Results 11 to 20 of about 362,132 (303)

Pituitary Adenoma Volumetry with 3D Slicer [PDF]

(2012) PLoS ONE 7(12): e51788, 2012
In this study, we present pituitary adenoma volumetry using the free and open source medical image computing platform for biomedical research: (3D) Slicer. Volumetric changes in cerebral pathologies like pituitary adenomas are a critical factor in treatment decisions by physicians and in general the volume is acquired manually.
J. Egger, T. Kapur, C. Nimsky, R. Kikinis   +3 more
arxiv   +3 more sources

Pituitary tumor transforming gene-1 haplotypes and risk of pituitary adenoma: a case-control study [PDF]

BMC Medical Genetics, 2011
Background It has been suggested that pituitary adenoma results from accumulation of multiple genetic and/or epigenetic aberrations, which may be identified through association studies.
A Fernandez, B Nilsson, C Saez, CJ McCabe, CS Carlson, D Giacomini, F Romero, F Salehi, G Vlotides, H Zou, HJ Karga, I Donangelo, J Etxabe, JC Barrett, Jinfang Liu, L Pei, L Pei, Lan Xiao, LJ Holt, R Yu, Shuai Chen, T Hamid, V Chesnokova, V Chesnokova, V Chesnokova, V Quereda, WY Cai, X Zhang, X Zhang, Yunsheng Liu, YY Shi, Zhixiong Liu   +31 more
core   +5 more sources

A nonsecreting suprasellar ectopic pituitary adenoma: A case report [PDF]

Radiology Case Reports
A pituitary adenoma in the suprasellar region without involvement of the Sella turcica is uncommon, with few examples recorded in the literature. Imaging, particularly magnetic resonance imaging, is critical for diagnosis.
Adam Sqalli Houssaini, MD, Sara Essetti, MD, Hajar Zebbakh, MD, Firdaous Touarsa, PhD, Mohamed Jiddane, PhD, Meriem Fikri, PhD   +5 more
doaj   +2 more sources

Clinical Biology of the Pituitary Adenoma

Endocrine reviews, 2022
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent and overwhelmingly benign, exhibiting a spectrum of diverse behaviors and
S. Melmed, U. Kaiser, M. Lopes, J. Bertherat, L. Syro, G. Raverot, M. Reincke, G. Johannsson, A. Beckers, M. Fleseriu, A. Giustina, J. Wass, Ken K. Y. Ho   +12 more
semanticscholar   +1 more source

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Journal of the Endocrine Society, 2021
The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups.
Ken K. Y. Ho, M. Fleseriu, U. Kaiser, R. Salvatori, T. Brue, M. Lopes, P. Kunz, M. Molitch, S. Camper, M. Gadelha, L. Syro, E. Laws, M. Reincke, H. Nishioka, A. Grossman, A. Barkan, F. Casanueva, J. Wass, A. Mamelak, L. Katznelson, A. J. van der Lely, S. Radovick, M. Bidlingmaier, M. Boguszewski, J. Bollerslev, A. Hoffman, N. Oyesiku, G. Raverot, Anat Ben-Shlomo, R. Fowkes, I. Shimon, H. Fukuoka, A. Pereira, Y. Greenman, A. Heaney, M. Gurnell, G. Johannsson, R. Osamura, M. Buchfelder, M. Zatelli, M. Korbonits, P. Chanson, N. Biermasz, D. Clemmons, N. Karavitaki, M. Bronstein, P. Trainer, S. Melmed   +47 more
semanticscholar   +1 more source

Primary application of cavernous sinus cranial nerve neurophysiological monitoring in extended endoscopic transsphenoidal surgery

Chinese Journal of Contemporary Neurology and Neurosurgery, 2021
Objective To investigate the effect of neurophysiological monitoring in extended endoscopic transsphenoidal surgery for cavernous sinus and clivus tumors.
MAO Zhi⁃gang, WEI Xin, CHEN Jin⁃ping, LI Yong⁃fu, WANG Hai⁃jun   +4 more
doaj   +1 more source

Clinical outcomes in central nervous system solitary-fibrous tumor/hemangiopericytoma: a STROBE-compliant single-center analysis

World Journal of Surgical Oncology, 2022
Background Solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are rare mesenchymal tumors in the central nervous system with a high tendency to relapse, having a significant impact on quality of life (QoL).
Yang Yu, Yu Hu, Liang Lv, Cheng Chen, Senlin Yin, Shu Jiang, Peizhi Zhou   +6 more
doaj   +1 more source

Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma

BMC Cancer, 2023
Glioblastoma multiforme (GBM) is recognized as the prevailing malignant and aggressive primary brain tumor, characterized by an exceedingly unfavorable prognosis.
Lirui Dai, Peizhi Zhou, Liang Lyu, Shu Jiang   +3 more
doaj   +1 more source

Exosomal miRNA Profiling is a Potential Screening Route for Non-Functional Pituitary Adenoma

Frontiers in Cell and Developmental Biology, 2022
Non-functional pituitary adenomas (NFPAs) are one of the most prevalent pituitary adenoma subtypes. The lack of reliable screening approach for NFPAs for the insidious clinical course usually leads to delays in medical therapy and consequently worse ...
Liang Lyu, Haiyan Li, Cheng Chen, Yang Yu, Li Wang, Senlin Yin, Yu Hu, Shu Jiang, Feng Ye, Peizhi Zhou   +9 more
doaj   +1 more source

Comprehensive In Silico Analysis of a Novel Serum Exosome-Derived Competitive Endogenous RNA Network for Constructing a Prognostic Model for Glioblastoma

Frontiers in Oncology, 2021
PurposeGlioblastoma (GBM) is one of the most aggressive brain tumors with high mortality, and tumor-derived exosomes provide new insight into the mechanisms of GBM tumorigenesis, metastasis and therapeutic resistance.
Zihao Wang, Zihao Wang, Xin Ji, Lu Gao, Lu Gao, Xiaopeng Guo, Xiaopeng Guo, Wei Lian, Wei Lian, Kan Deng, Kan Deng, Bing Xing, Bing Xing   +12 more
doaj   +1 more source